Back to search results

Understanding Pancreatic Disease: A Registry and Biospecimen Bank

This study is creating a registry and a collection of biological samples (biospecimen bank) to better understand pancreatic diseases like pancreatic cancer. There isn't a specific treatment being tested. You could join if you are 18 to 85 years old and have been diagnosed with pancreatic cancer, have a pre-cancerous lesion in your pancreas, or are at high risk for pancreatic cancer. The goal is to build this registry and bank within one year to help future research into the causes and biology of pancreatic cancer. The study is currently unclear on its recruitment status.

Study design
This is an observational study aiming to enroll 1000 participants. It is designed to collect information and samples without testing a specific intervention.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary goal of creating the registry and bank is measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01102556

PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease

Recruiting
Not specifiedAges 18–85Observational
Columbia University
~1,000 participants
Updated 2026-04-02 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Creation of a registry and blood/tissue bank
Measured over 1 year

Conditions

Pancreatic Cancer

Explore related trials

Pancreatic CarcinomaPancreatitisPre-Neoplastic LesionsBRCA1 GeneBRCA2 Gene

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Beth Schrope, MD, PhD, FACS · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

Vilma Rosario
[email protected]
212-305-6033
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Individuals who have been diagnosed with pancreatic cancer or suspicion of pancreatic cancer, a pre-neoplastic lesion in the pancreas who are 18 years or older
Individuals identified to be high risk for developing pancreatic cancer who are 18 years or older based on the following criteria:
The modified clinical Bethesda criteria for hereditary nonpolyposis colorectal cancer (HNPCC), which are as follows: individuals with 2 HNPCC-associated cancers (colon, endometrial, small bowel, hepatobiliary, pancreatic, genitourinary, or gastric), including synchronous or metachronous lesions; individuals with colon cancer and a first degree relative with an HNPCC-associated tumor and/or colonic adenoma (1 cancer diagnosed at age \<45 years and the adenoma diagnosed at age \<40 years); individuals with colon or endometrial cancer diagnosed at \<50 years; individuals with right-sided colon cancer having an undifferentiated pattern (solid/cribiform) or signet cell histopathology diagnosed at \<45 years; or individuals with adenomas diagnosed at \<40 years.
Those with a personal or family history of other pancreatic cancer associated syndromes including: Peutz-Jeghers syndrome, familial pancreatic cancer syndrome, familial breast cancer syndrome associated with BReast CAncer genes 1 or 2 (BRCA-2 or BRCA-1), hereditary pancreatitis, familial atypical multiple mole melanoma, and others.
Patients in a family with a genetically determined cancer predisposition syndrome.
Patients with a personal history of a gastrointestinal malignancy at age \<45 years.
Individuals at high-risk based on personal or family history, but not related to a known pancreatic cancer syndrome include the following: those with a personal history of pancreatic cancer, or a pre-neoplastic pancreatic lesion; those with a family history of two or more individuals with cancer, at least one of which is reported to be a gastrointestinal malignancy; a history of early onset (\<50 years) gastrointestinal cancer in the individual or a family member; a history of multiple primary cancers, at least one of which is a gastrointestinal primary, or a family member of an individual meeting this criterion.

Exclusion

Inability to obtain informed consent for study enrollment.
Under the age of 18 years old.

What this trial measures

  • Creation of a registry and blood/tissue bank1 year

    The primary aims of this project are to create a registry, and blood and tissue bank for individuals at risk for pancreatic cancer.